» Articles » PMID: 19443368

Prognostic Value of Serum and Ascites Levels of Estradiol, FSH, LH and Prolactin in Ovarian Cancer

Overview
Journal Anticancer Res
Specialty Oncology
Date 2009 May 16
PMID 19443368
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: The aim of this study was to investigate the influence of sex hormone levels on tumor biology and patients' outcome in ovarian cancer.

Patients And Methods: One hundred and six patients with ovarian cancer were enrolled into this prospective study. Serum and ascites samples were obtained intraoperatively. Concentrations of estradiol, FSH, LH and prolactin were measured and correlated with parameters of tumor biology, such as FIGO stage, tumor spread and postoperative tumor residual mass. Patients with primary ovarian cancer were compared to patients with recurrent disease. Influence factors on progression-free survival and overall survival were analyzed using the Kaplan-Meyer method.

Results: Serum FSH concentrations were significantly higher and estradiol concentrations in ascites were significantly lower in patients with recurrent disease. According the multivariate analysis, only FSH level in ascites was seen to be an independent prognostic factor for patients' survival.

Conclusion: High level of FSH in the ascites provides prognostic information in patients with ovarian cancer and is inversely correlated with patients' survival.

Citing Articles

Analysis of Prediagnostic Circulating Levels of Gonadotropins and Androgens with Risk of Epithelial Ovarian Cancer.

Parchwani D, Dholariya S, Takodara S, Singh R, Sharma V, Saxena A J Lab Physicians. 2022; 14(1):47-56.

PMID: 36105913 PMC: 9465621. DOI: 10.1055/s-0041-1741443.


Characterizing Endocrine Status, Tumor Hypoxia and Immunogenicity for Therapy Success in Epithelial Ovarian Cancer.

Pereira M, Matuszewska K, Jamieson C, Petrik J Front Endocrinol (Lausanne). 2021; 12:772349.

PMID: 34867818 PMC: 8635771. DOI: 10.3389/fendo.2021.772349.


Hormone therapy for ovarian cancer: Emphasis on mechanisms and applications (Review).

Li H, Liu Y, Wang Y, Zhao X, Qi X Oncol Rep. 2021; 46(4).

PMID: 34435651 PMC: 8424487. DOI: 10.3892/or.2021.8174.


DEAD-Box Helicase 4 (Ddx4) Stem Cells Sustain Tumor Progression in Non-Serous Ovarian Cancers.

DOronzo S, Silvestris E, Lovero D, Cafforio P, Duda L, Cormio G Int J Mol Sci. 2020; 21(17).

PMID: 32847044 PMC: 7503840. DOI: 10.3390/ijms21176096.


Establishment of A Reversibly Inducible Porcine Granulosa Cell Line.

Bai Y, Zhu C, Feng M, Pan B, Zhang S, Zhan X Cells. 2020; 9(1).

PMID: 31936362 PMC: 7017277. DOI: 10.3390/cells9010156.